Comparison of radioiodinated TOC, TOCA and Mtr-TOCA: The effect of carbohydration on the pharmacokinetics

European Journal of Nuclear Medicine

Volumn 29, Issue 1, 2002, Pages 28-38

  Wester, Hans Jürgen ^a   Schottelius, Margret ^a   Scheidhauer, Klemens ^a   Reubi, Jean Claude ^b   Wolf, Ingo ^a   Schwaiger, Markus ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Carbohydration; Glycation; Octreotide; Radioiodination; Somatostatin

Indexed keywords

MALTOTRIOSE OCTREOTATE[3 TYROSINE] I 125; OCTREOTATE[3 TYROSINE] I 125; OCTREOTIDE[3 TYROSINE] I 125; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

AGED; AMINO TERMINAL SEQUENCE; ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CARBOHYDRATION; CARBOXY TERMINAL SEQUENCE; CARCINOID; CARCINOMATOSIS; CASE REPORT; CHEMICAL REACTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ACTIVITY; DRUG BINDING; DRUG DETERMINATION; DRUG DISTRIBUTION; DRUG SELECTIVITY; DRUG UPTAKE; GENETIC TRANSFECTION; HUMAN; IMAGING; INTESTINE; ISOTOPE LABELING; KIDNEY; LIVER; LIVER METASTASIS; MALE; MOUSE; NONHUMAN; NUDE MOUSE; OXIDATION; PLASMA CLEARANCE; RADIOIODINATION; RAT; SCINTIGRAPHY; SMALL INTESTINE; TUMOR XENOGRAFT;

AGED; ANIMALS; CARCINOID TUMOR; CELLS, CULTURED; FEMALE; GAMMA CAMERAS; GLYCOSYLATION; HUMANS; IODINE RADIOISOTOPES; MALE; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; OCTREOTIDE; PANCREATIC NEOPLASMS; RADIOPHARMACEUTICALS; RECEPTORS, SOMATOSTATIN; TISSUE DISTRIBUTION; TRISACCHARIDES;

EID: 0036166722     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-001-0669-1     Document Type: Article

References (35)

1. Somatostatin receptor imaging in the localisation of endocrine tumours
2. 3-octreotide: The Rotterdam experience with more than 1000 patients
3. Yttrium-90 DOTATOC: First clinical results
4. 3]octreotide, a promising somatostatin analogue for radionuclide therapy
5. 90Y-labelled analogue
6. OctreoTher. Ongoing early clinical development of somatostatin-receptor-targeted radionuclide antineoplastic therapy
7. In vivo use of a radioiodinated somatostatin analogue: Dynamics, metabolism and binding to somatostatin receptor-positive tumours in man
8. Dosimetry and biodistribution of a iodine-123 labelled somatostatin analog in patients with neuroendocrine tumours
9. Localisation of endocrine-related tumours with radioiodinated analogue of somatostatin
10. Iodine-131 labelled octreotide: Not an option for somatostatin receptor therapy
11. 86Y-DTPA-octreotide
12. Hepatic uptake of octreotide, a long-acting somatostatin analogue, via a bile acid transport system
13. Hepatocellular transport of cyclosomatostatins: Evidence for a carrier system related to the multispecific bile acid transporter
14. Hepatocellular uptake of peptide by bile acid transporter: Relationship of carrier-mediated transport of linear peptides with renin-inhibiting activity to multispecific bile acid carriers
15. Carrier mediated active transport of BQ-123, a peptidic endothelin antagonist into rat hepatocyte
16. 3 integrin antagonists: A new class of tracers for tumour targeting
17. Carrier mediated hepatic uptake of the cationic cyclopeptide, octreotide, in rats
18. SDZ CO 611: A highly potent glycated analog of somatostatin with improved oral activity
19. Heterogeneity in hepatic transport of somatostatin analog octapeptides
20. Structural effects of glycosylation on the C-terminal pentapeptide of peptide T
21. Enkephalin glycopeptide analogues produce analgesia with reduced dependence liability
22. Improvement of intestinal absorption of peptide drugs by glycosylation: Transport of tetrapeptide by the sodium ion-dependent D-glucose transporter
23. Glycosylated RGD-peptides: Tracer for tumour targeting and angiogenesis imaging with improved pharmacokinetics
24. 18F-labelled RGD-containing glycopeptide and positron emission tomography
25. 3-octreotide: Precursors for I-123- and F-18-labelled sst-binding SPECT/PET tracers with improved biodistribution
26. Glycation of radioiodinated octreotides increases renal excretion and tumour uptake
27. 111In-labelled somatostatin analogues for tumour scintigraphy and radionuclide therapy
28. Radiolabelled ligand-octreotate conjugates: Evaluation of potential diagnostic and therapeutic radiopharmaceutical agents targeted to somatostatin receptors
29. 64Cu-labelled somatostatin analogues in vitro and in a tumour bearing rat model: Evaluation of new derivatives for positron emission tomography imaging and targeted radiotherapy
30. Glycated radioiodinated octreotides and octreotates with renal excretion and increased tumour uptake for SSTR scintigraphy and peptide receptor radionuclide therapy (PRRT)
31. 3-octreotide reveals high potential of glycated and radiometallated octreotide derivatives for diagnosis and therapy
32. Octanol-water partition of nonzwitter-ionic peptides: Predictive power of a molecular size-based model
33. Affinity profiles for human somatostatin receptor sst1-sst5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use
34. Functional somatostatin receptors on a rat pancreatic acinar cell line
35. Somatostatin receptor sst1-sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands